<link rel="stylesheet" href="https://s3.amazonaws.com/aga-lms-assets/styles/master_styles.css">
<div class="row">
  <!-- Left Side Content -->
  <div class="col-md-7">

    <!-- Book -->

    <nav>
      <div class="nav nav-tabs"
      id="nav-tab"
      role="tablist">
      <a class="nav-item nav-link active"
      id="nav-tab-one"
      data-toggle="tab"
      href="#nav-one"
      role="tab"
      aria-controls="nav-one"
      aria-selected="true">Details</a>
      <a class="nav-item nav-link"
      id="nav-tab-two"
      data-toggle="tab"
      href="#nav-two"
      role="tab"
      aria-controls="nav-two"
      aria-selected="false">Credit Information</a>
      <a class="nav-item nav-link"
      id="nav-tab-three"
      data-toggle="tab"
      href="#nav-three"
      role="tab"
      aria-controls="nav-three"
      aria-selected="false">Pricing</a>
    </div>
  </nav>
  <div class="tab-content"
  id="nav-tabContent">
  <div class="tab-pane fade show active"
  id="nav-one"
  role="tabpanel"
  aria-labelledby="nav-tab-one">
  <!-- Tab One -->
  <p>Learn about how biosimilars are used in the practice of gastroenterology in the US from this recording of
    the live session held during DDW 2017 in Chicago (recorded May 9, 2017). Panelists and presentations
    include:<br>
  </p>
  <ul>
    <li>Introduction to Biosimilars (15 minutes)<br>
    Gary R. Lichtenstein, MD, AGAF</li>
    <li>The US Biosimilars Regulatory Pathway (20 minutes)<br>
    M. Stacey Ricci, M.Eng., Sc.D.</li>
    <li>Clinical Considerations In Use Of Biosimilars For Gastrointestinal Disorders (20 minutes)<br>
    Brian G. Feagan, MD</li>
    <li>Why Patients Should Know About Biosimilars (20 minutes)<br>
    David T. Rubin, MD, AGAF</li>
    <li>Panel Discussion (15 minutes)</li>
  </ul>
  <p>This program is supported by independent educational grants from Boehringer Ingelheim Pharmaceuticals,
  Inc. and Pfizer Inc.</p>
  <p>This session is sponsored by the AGA Biosimilars Advisory Panel, Clinical Practice, Immunology,
    Microbiology &amp; Inflammatory Bowel Diseases, and is a collaboration of the AGA Institute and the
  Crohn’s and Colitis Foundation.</p>
  <p class="pt-4 text-center">
    <a href="http://agau.gastro.org/diweb/gateway/init/1/f/catalog*2Fitem*2Feid*2FBIOSIM02"
    class="btn btn-orange"> <i class="fa fa-external-link"></i> Sign in to access</a>
  </p>
  <p><i class="fas fa-info-circle fa-lg"></i>&nbsp;<strong><em>After you sign in, please click the "Launch"
  button on the top of this page to access the videos.</em></strong></p>

  <p class="mt-1">&nbsp;</p>

</div>
<!--~ Tab Two ~-->
<div class="tab-pane fade"
id="nav-two"
role="tabpanel"
aria-labelledby="nav-tab-two">
<!-- Tab Two Content -->
<h3 class="mt-4">CME / Maintenance of Certification (MOC) Information</h3>
<p>The American Gastroenterological Association (AGA) Institute is accredited by the Accreditation Council
for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.</p>
<p>The AGA Institute designates this enduring activity for a maximum of 1.5&nbsp;<em>AMA PRA Category 1
Credits</em>™. Physicians should claim only the credit commensurate with the extent of their
participation in the activity.</p>
<p>In accordance with the ACCME’s Standards for Commercial Support of Continuing Medical Education, all
  faculty and planning partners must disclose any financial relationship(s) or other relationship(s) held
  within the past 12 months. The AGA Institute implements a mechanism to identify and resolve all conflicts
of interest prior to delivering the educational activity to learners.</p>
<p>Successful completion of this CME activity enables the participant to earn up to 1.5 MOC points in the
  American Board of Internal Medicine’s (ABIM) MOC program. Participants will earn MOC points equivalent to
  the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to
submit participant completion information to ACCME for the purpose of granting ABIM MOC points.</p>
<p><strong>CME/MOC expiration date: July 19, 2019</strong></p>
<p>If you have any questions, please email&nbsp;<a
 href="mailto:education@gastro.org">education@gastro.org</a></p>
 <h4>Faculty Relationship and Financial Disclosures</h4>
 <p><strong><a
   href="https://cdn.mycrowdwisdom.com/aga/resources/BIOSIM02_Advent_of_Biosimilars_Financial_Disclosures.pdf"
   title=""
   target="_blank">Click here to view financial disclosures for presenters</a></strong>.</p>
   <p><strong>Planning Committee</strong></p>
   <p>Gary R. Lichtenstein, MD, AGAF</p>
   <ul>
    <li>Consultant: Abbvie, Alaven, Celgene/Santarus/Receptos, Ferring, Hospira, Janssen Orthobiotech,
    Luitpold/American Reagent, Pfizer, Prometheus, Salix Pharmaceuticals,</li>
    <li>Shire, Takeda, UCB</li>
    <li>Grant/Research Support: Celgene/Santarus/Receptos, Takeda</li>
    <li>Honoraria: Clinical Advances in Gastroenterology, Ironwood, McMahon Publishing,</li>
    <li>Merck, Romarck, Springer</li>
    <li>Royalty: SLACK, Inc.</li>
  </ul>
  <p><strong>AGA Staff</strong></p>
  <p>Maura H. Davis<br>
  Disclosed no relevant financial relationships.</p>
  <p>Monique S. Dyson, MS, CHES<br>
  Disclosed no relevant financial relationships.</p>
  <p>Alison Kim, PhD<br>
  Disclosed no relevant financial relationships.</p>
  <p><strong>Crohn’s &amp; Colitis Foundation Staff</strong></p>
  <p>Orna Ehrlich<br>
  Disclosed no relevant financial relationships.</p>
  <p>Laura Wingate<br>
  Disclosed no relevant financial relationships.</p>
  <h4 class="pt-3">&nbsp;</h4>
</div>
<!--~ /End Tab Two ~-->

<!--~ Tab Three ~-->
<div class="tab-pane fade"
id="nav-three"
role="tabpanel"
aria-labelledby="nav-tab-three">
<!-- Tab Three Content -->

<table width="50%"
cellpadding="0"
cellspacing="0"
class="table table-bordered">
<thead>
  <tr style="background-color:#102033; color:#FFFFFF;">
    <th width="226"
    align="left"
    scope="col">
    Member
  </th>
  <th width="190"
  align="left"
  scope="col">
  Nonmember
</th>
</tr>
</thead>
<tbody>
  <tr>
    <td>Free (Sign in to access)</td>
    <td>Free (Sign in to access)</td>
  </tr>
</tbody>
</table>
</div>
</div>


<div class="row pt-5">
  <div class="container">
    <hr>
    <p>If you have any questions please email the <a href="mailto:education@gastro.org ">AGA Education
    Department</a>.
  </p>
</div>
</div>
</div>

<!-- Right Side Card Content -->
<div class="col-md-5">
  <!-- * Accomidations * -->
  <div class="container mt-3">
    <div class="row ">
      <div class="card text-light card-case"
      style="background-color:rgb(25, 36, 51); width: 20rem">
      <img src="https://s3.amazonaws.com/aga-lms-assets/images/OnDemand_180x180-1547234219168.jpg"
      class="card-img-top bg-light"
      alt="card header image" />
      <div class="card-body">
        <p class="card-text pt-3">
          <i class="fas fa-alarm-clock text-warning fa-2x"></i> Time to Complete: 1 hour and 30 minutes
        </p>

        <p class="card-text pt-3">
          <i class="fas fa-calendar-alt text-warning fa-2x"></i> Released: July 17, 2017
        </p>

        <p class="card-text pt-3">
          <i class="fas fa-hourglass-half text-warning fa-2x"></i> Credit Expires: July 19, 2019
        </p>
        <p class="text-body text-center pt-3">
          <a href="https://cdn.mycrowdwisdom.com/aga/resources/BIOSIM02_Advent_of_Biosimilars_Financial_Disclosures.pdf"
          target="_blank">
          <button class="btn btn-light btn-orange-on-blue"
          style="background-color:#FAA61A; border:1px solid #FAA61A;"> Disclosures
        </button>
      </a> </p>
    </div>
  </div>
</div>
</div>
</div>
</div>
